Market Tracker

07/22 9:10am ET

Depomed Inc (NASDAQ:DEPO)

11.46
Data as of Jul 21
 +0.05 / +0.44%
Today’s Change
5.93
Today|||52-Week Range
15.39
+8.32%
Year-to-Date

Today’s Trading

Previous close11.41
Today’s open11.35
Day’s range-- - --
Volume545,358
Average volume (3 months)981,537
Market cap$664.6M
Dividend yield--
Data as of 07/21/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)+72.00%
Revenue growth (last year)+47.78%
P/E ratio10.0
Price/Sales4.47
Price/Book4.78

Competitors

 Today’s
change
Today’s
% change
NEPTNeptune Technologies...0.000.00%
CMPERelmada Therapeutics...0.000.00%
TEVATeva Pharmaceutical ...-0.43-0.79%
Data as of 07/21/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$134.2M
Annual profit (last year)$43.3M
Net profit margin32.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts